Yida Corporation: Controlling subsidiary plans to merge with its wholly-owned subsidiary.

Yida Group announced that its holding subsidiary, Taixing Yida Chemical Co., Ltd., plans to absorb and merge its wholly-owned subsidiary, Wanqi Biotechnology Co., Ltd. As of September 30, 2025, Taixing Yida's total assets were 1.358 billion yuan, total liabilities were 1.368 billion yuan, revenue from January to September 2025 was 225 million yuan, and net profit was -126 million yuan; as of November 18, 2025, Wanqi Biotechnology's total assets were 7.1882 million yuan, total liabilities were 110,700 yuan, there was no revenue from January to November 18, 2025, and net profit was -2.8632 million yuan. The merger does not involve payment of consideration, and Wanqi Biotechnology's legal person status will be cancelled after completion.